Anti-FGA Protein A Scaffold
|Anti-Human Fibrinogen Protein A scaffold
- Species Reactivity
- Expression Host
- E. coli
- This Anti-Fibrinogen Protein A scaffold Molecule is modified with a unique C-terminal cysteine for directed single-point chemical modification, facilitating coupling to matrices. However, tail-to-tail dimers are spontaneously generated via a disulphide bridge betwe
- Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Antigen Description
- Defects in FGA are a cause of congenital afibrinogenemia (CAFBN). This is a rare autosomal recessive disorder characterized by bleeding that varies from mild to severe and by complete absence or extremely low levels of plasma and platelet fibrinogen.
Note: The majority of cases of afibrinogenemia are due to truncating mutations. Variations in position Arg-35 (the site of cleavage of fibrinopeptide a by thrombin) leads to alpha-dysfibrinogenemias.
Defects in FGA are a cause of amyloidosis type 8 (AMYL8); also known as systemic non-neuropathic amyloidosis or Ostertag-type amyloidosis. AMYL8 is a hereditary generalized amyloidosis due to deposition of apolipoprotein A1, fibrinogen and lysozyme amyloids. Viscera are particularly affected. There is no involvement of the nervous system. Clinical features include renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash.
- eukaryotic cell surface binding; protein binding; protein binding, bridging; receptor binding.
- Gene ID
- Fib2; MGC119422; MGC119423; MGC119425; FGA; fibri- nogen alpha chain; OTTHUMP00000197063; OTTHUMP 00000197064; fibrinogen, A alpha polypeptide
- Download Datasheet:
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us